
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Vancomycin-resistant enterococci risk factors
Introduction
Overview
Overview
Prior treatment with antibiotics is common in nearly all patients colonized or infected with MDR enterococci. Clindamycin, cephalosporin,aztreonam, ciprofloxacin, aminoglycoside, and metronidazole use is equally or more often associated with colonization or infection with MDR enterococci than vancomycin use. Other risk factors include prolonged hospitalization, high severity of illness score, intraabdominal surgery, renal insufficiency, enteral tube feedings, and exposure to specific hospital units, nurses, or contaminated objects and surfaces within patient-care areas.
Risk Factors
Risk Factors
The following persons are at an increased risk becoming infected with VRE:
- Persons who have been previously treated with vancomycin and combinations of other antibiotics such as penicillin and gentamicin.
- Persons who are hospitalized, particularly when they receive antibiotic treatment for long periods of time.
- Persons with weakened immune systems such as patients in Intensive Care Units, or in cancer or transplant wards.
- Persons who have undergone surgical procedures such as abdominal or chest surgery.
- Persons with medical devices that stay in for some time such as urinary catheters or central intravenous catheters.
References
References
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
